Page 122 - Catálogo de Patentes e Tecnologias - 2021
P. 122
REFERENCIAS
1. Lindgren, Mats, and Hans Bandhold. Scenario planning. Palgrave, 2003.
2. Schoemaker, Paul JH. "Scenario planning: a tool for strategic thinking." Sloan management review 36.2 (1995): 25-50.
3. Moss, Giles David. Pharmaceuticals-Where's the Brand Logic?: Branding Lessons and Strategy. CRC Press, 2016.
4. Amabile, Teresa M. “Creativity and innovation in organizations.” (1996).
5. Boon, Wouter, and Jakob Edler. “Demand, challenges, and innovation. Making sense of new trends in innovation policy.” Science and Public Policy 45.4 (2018): 435-447.
6. Botelho, Delane, and Leandro Guissoni. “Varejo: competitividade e inovação.” Revista de Administração de Empresas 56.6 (2016): 596-599.
7. Buss, Paulo Marchiori, et al. “Desenvolvimento, saúde e política internacional: a dimensão da pesquisa & inovação.” Cadernos de Saúde Pública 32 (2016): e00046815.
8. Byron, Kris, and Shalini Khazanchi. “Rewards and creative performance: a meta-analytic test of theoretically derived hypotheses.” Psychological bulletin 138.4 (2012): 809.
9. Chaudhary, Vrantika, Sumit Jangra, and Neelam R. Yadav. “Nanotechnology based approaches for detection and delivery of microRNA in healthcare and crop protection.” Journal
of nanobiotechnology 16.1 (2018): 40.
10. Cunningham, Francis J., et al. “Nanoparticle-mediated delivery towards advancing plant genetic engineering.” Trends in biotechnology 36.9 (2018): 882-897.
11. Dewett, Todd. “Linking intrinsic motivation, risk taking, and employee creativity in an R&D environment.” R&d Management 37.3 (2007): 197-208.
12. Di Sia, Paolo. “Nanotechnology among innovation, health and risks.” Procedia-Social and Behavioral Sciences 237 (2017): 1076-1080.
13. Dodziuk, Helena. “Applications of 3D printing in healthcare.” Kardiochirurgia i torakochirurgia polska= Polish journal of cardio-thoracic surgery 13.3 (2016): 283.
14. Etzkowitz, Henry, and Chunyan Zhou. “Hélice Tríplice: inovação e empreendedorismo universidade-indústria-governo.” Estudos avançados 31.90 (2017): 23-48.
15. Fletcher, Andrew J., et al. Principles and practice of pharmaceutical medicine. John Wiley & Sons, 2003.
16. Fonseca, Amanda Luiza, et al. “Epidemiologic aspects of toxoplasmosis and evaluation of its seroprevalence in pregnant women.”
Equipe 17. Giuriatti, Tiago, et al. “Análise do P&D Brasileiro com Uso da Nanotecnologia em Medicamentos para Uso Humano: pesquisas, tecnologias e produtos.” Cadernos de Prospec-
ção 13.1 (2020): 225.
18. Hay, Michael, et al. “Clinical development success rates for investigational drugs.” Nature biotechnology 32.1 (2014): 40-51.
Autor e Desenvolvedor: Marco Lopes 1429715-4 19. Horvath, Balint, et al. “Investigating the current business model innovation trends in the biotechnology industry.” Journal of Business Economics and Management 20.1 (2019):
63-85.
Colaboradores: Bruno Castro e Sílvia Fialho 20. Isgandarov, Nijat. “4D Printing Processes and Healthcare Applications.” (2019).
Revisores: Mateus Prata e Nayane Breder 21. Jacobs, Jesse V., et al. “Employee acceptance of wearable technology in the workplace.” Applied ergonomics 78 (2019): 148-156.
22. Lichtenberg, Frank R. The benefits of pharmaceutical innovation: health, longevity, and savings. Montreal Economic Institute, 2016.
23. Lichtenberg, Frank R., et al. “The impact of drug vintage on patient survival: a patient-level analysis using Quebec’s provincial health plan data.” Value in Health 12.6 (2009):
847-856.
24. Loncar-Turukalo, Tatjana, et al. “Literature on wearable technology for connected health: Scoping review of research trends, advances, and barriers.” Journal of medical Internet
research 21.9 (2019): e14017.
25. Madjar, Nora, Ellen Greenberg, and Zheng Chen. “Factors for radical creativity, incremental creativity, and routine, noncreative performance.” Journal of applied psychology 96.4
(2011): 730.
26. Manninen, Kaisa, et al. “Do circular economy business models capture intended environmental value propositions?.” Journal of Cleaner Production 171 (2018): 413-422.
27. Montaldo, Hugo H. “Genetic engineering applications in animal breeding.” Electronic Journal of Biotechnology 9.2 (2006): 0-0.
28. Oliveira, Guilherme Gregorio De. “Agenda Nacional De Prioridades De Pesquisa Em Saúde No Brasil (Anpps): Revisão Da Subagenda Para A Saúde Mental.” (2017).
29. Portaria MCTIC nº 1.122, de 19.03.2020. Brasília: MCTIC, 2020. Disponível em: <https:// www.mctic.gov.br/mctic/opencms/legislacao/portarias/Portaria_MCTIC_n_1122_
de_19032020.html>
30. Rajkomar, Alvin, Jeffrey Dean, and Isaac Kohane. “Machine learning in medicine.” New England Journal of Medicine 380.14 (2019): 1347-1358.
31. Robson, Kelsey, et al. “A 20-year analysis of reported food fraud in the global beef supply chain.” Food Control (2020): 107310. Revista da Sociedade Brasileira de Medicina
Tropical 45.3 (2012): 357-364.
32. Scannell, Jack W., et al. “Diagnosing the decline in pharmaceutical R&D efficiency.” Nature reviews Drug discovery 11.3 (2012): 191.
33. Tu, Zhuchi, et al. “CRISPR/Cas9: a powerful genetic engineering tool for establishing large animal models of neurodegenerative diseases.” Molecular neurodegeneration 10.1
(2015): 1-8.
34. US Congress Office of Technology Assessment. Pharmaceutical R&D: costs, risks, and rewards. Washington (DC); 1993.Available from: https://www.princeton.edu/~ota/
disk1/1993/9336/9336.PDF
35. Zen, Aurora Carneiro, et al. “Rota da inovação: uma proposta de metodologia de gestão da inovação.” RAC-Revista de Administração Contemporânea 21.6 (2017): 875-892.
36. Zhang, Zhizhou, Kahraman G. Demir, and Grace X. Gu. “Developments in 4D-printing: a review on current smart materials, technologies, and applications.” International Journal
of Smart and Nano Materials 10.3 (2019): 205-224.
116 Catálogo de Patentes e Tecnologias Diretoria de Pesquisa e Desenvolvimento 117
DPD - 2021
FUNED - 2021
